The Bulletin
Times Advertising


.

Medtronic announces FDA approval of Simplera™ CGM and global partnership with Abbott

  • Written by PR Newswire
Medtronic announces FDA approval of Simplera™ CGM and global partnership with Abbott

Medtronic Diabetes expands CGM offerings to meet more people where they are in their diabetes journey

DUBLIN, Aug. 7, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for its Simplera™ continuous glucose monitor (CGM) — the...

The Bulletin Magazine

Who Should Consider Mole Mapping in Melbourne?

Why Buy Carbohydrate Supplements Are Essential For Weight Gain And Bodybuilding Performance

Engineered Timber Floors Melbourne: Creating Timeless And Durable Interiors

Year 12 Tutoring Helping Students Navigate Their Most Important Academic Year

Simple Home Upgrades That Improve Security, Comfort and Everyday Living

What is a Design and Build Contract? A Complete Guide

How Melbourne Homeowners Keep Their Homes Clean Year-Round (Without Spending Their Weekends Doing It)

Why Choosing The Right GP Bundoora Is Key To Long-Term Health Management

Why BMW Used Cars Are A Smart Choice For Modern Drivers

SMSF Loan Experts Guiding Smarter Property Investment Through Super

Why Professional Cleaning Services Are Essential For Commercial Workspaces

From Purchase to Protection: What Happens After You Buy a Home